Literature DB >> 2839131

Phenotypic transformation of primary mouse fibroblasts by BPV 1 DNA.

R Mäntyjärvi1, H Sarkkinen, S Parkkinen, A Ryhänen, H Karjalainen, K Syrjänen, S Syrjänen.   

Abstract

Cultures of primary fibroblasts of C57BL/6J mice were used as targets for transformation by bovine papillomavirus type 1 (BPV 1) DNA. Although no foci were observed, several lines of transformed cells were established by subculturing. These immortalized cell lines had in vitro growth characteristics in high and low serum media and saturation densities typical of transformed cells. Karyotype analyses revealed extensive aneuploidic changes. In two of the three cell lines analyzed, viral DNA was present in monomeric episomal form, in the third cell line all viral sequences were found in the high molecular weight region of a Southern blot. Despite the transformed phenotype, only one of the cell lines was tumorigenic in nude mice at a low level.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839131     DOI: 10.1007/BF01310904

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  20 in total

1.  Early chromosome changes in diploid Chinese hamster cells after infection with Simian virus 40.

Authors:  J M Lehman
Journal:  Int J Cancer       Date:  1974-02-15       Impact factor: 7.396

2.  A quantitative in vitro focus assay for bovine papilloma virus.

Authors:  I Dvoretzky; R Shober; S K Chattopadhyay; D R Lowy
Journal:  Virology       Date:  1980-06       Impact factor: 3.616

3.  Levels of bovine papillomavirus RNA and protein expression correlate with variations in the tumorigenic phenotype of hamster cells.

Authors:  Y L Zhang; A Lewis; M Wade-Glass; R Schlegel
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

4.  Bovine papilloma virus plasmids replicate randomly in mouse fibroblasts throughout S phase of the cell cycle.

Authors:  D M Gilbert; S N Cohen
Journal:  Cell       Date:  1987-07-03       Impact factor: 41.582

5.  Integration sites of human papillomavirus 18 DNA sequences on HeLa cell chromosomes.

Authors:  N C Popescu; J A DiPaolo; S C Amsbaugh
Journal:  Cytogenet Cell Genet       Date:  1987

6.  In vitro transformation by bovine papilloma virus.

Authors:  H R Meischke
Journal:  J Gen Virol       Date:  1979-06       Impact factor: 3.891

7.  Relationship of cell growth behavior in vitro to tumorigenicity in athymic nude mice.

Authors:  C D Stiles; W Desmond; L M Chuman; G Sato; M H Saier
Journal:  Cancer Res       Date:  1976-09       Impact factor: 12.701

8.  Reversion of bovine papillomavirus-induced transformation and immortalization by a xanthate compound.

Authors:  E Amtmann; K Müller; A Knapp; G Sauer
Journal:  Exp Cell Res       Date:  1985-12       Impact factor: 3.905

9.  Intracellular surveillance of persisting viral infections. Human genital cancer results from deficient cellular control of papillomavirus gene expression.

Authors:  H zur Hausen
Journal:  Lancet       Date:  1986-08-30       Impact factor: 79.321

10.  Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences.

Authors:  M F Law; D R Lowy; I Dvoretzky; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

View more
  3 in total

1.  Generation of cell-mediated cytotoxicity against bovine-papilloma-virus-transformed primary mouse cell lines.

Authors:  A Laatikainen; H Karjalainen; H Sarkkinen; K Syrjänen; R Mäntyjärvi
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

2.  Tumorigenicity and H-2 expression of papillomavirus-transformed mouse cell lines.

Authors:  A Laatikainen; H Karjalainen; H Jägerroos; H Sarkkinen; R Mäntyjärvi
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

3.  Effect of interferon gamma on the sensitivity of bovine-papilloma-virus(BPV1)-transformed cell lines to cell-mediated cytotoxicity.

Authors:  A Laatikainen; L Schultz-Suhonen; R Mäntyjärvi
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.